BioPharmSignal logoBioPharmSignal

Biotech News

Achieve Life Sciences Strengthens Board and Commercial Leadership with Three Senior Appointments from Team Previously at Verona Pharma

Achieve Life Sciences (ACHV)Achieve Life SciencesCommercial

ACHV (ACHV) appears in the live feed after a catalyst-style update. The headline is surfaced in real time so readers can move from signal to source without leaving the product flow.

The source domain is achv.com. BioPharmSignal keeps the ticker, timestamp, and source together for faster review before the wider market catches up.

The original release is available below in a new tab so readers can continue into the full source when needed.

Related news

ACHVAchieve Life Sciences2026-08-03 12:30 EST

Achieve Life Sciences Appoints Ronald Dadino and Gloria Cosgrove to Lead CMC, Supply Chain, and Quality

ACHVAchieve Life Sciences2026-03-26 12:30 EST

Achieve Life Sciences Announces Publication in Nicotine & Tobacco Research Linking Cytisinicline's Receptor Selectivity to Low Nausea Rates and Favorable Tolerability

RGENRepligen2025-12-16 12:30 EST

Repligen Introduces Next-Generation Chromatography Resins to Advance New Modality Workflows

AZTAAzenta Life Sciences2026-04-07 12:15 EST

Azenta Life Sciences Announces Leadership Transition to Accelerate Gene Synthesis Strategy and Multiomics Execution

KZRKezar Life Sciences2020-05-04 20:01 EST

Kezar Life Sciences Strengthens Executive Team with the Appointment of Noreen R. Henig, MD as Chief Medical Officer

TECHBio-Techne2026-06-25 10:10 EST

Merck KGaA, Darmstadt, Germany, Agrees to Acquire Bio-Techne, Strengthening Leadership Position in Fast-Growing Life Sciences Markets

TECHBio-Techne2026-02-11 14:00 EST

Bio-Techne Announces Changes to its Leadership Team

WVEWave Life Sciences2026-08-05 20:05 EST

Wave Life Sciences Announces Expected Completion Date for Redomiciliation to Delaware

WVEWave Life Sciences2026-07-07 20:15 EST

Wave Life Sciences Announces Singapore Court Hearing, to be held on July 14, 2026 to Approve Scheme of Arrangement for Redomiciliation

SLSSELLAS Life Sciences Group, Inc.2026-05-12 20:05 EST

SELLAS Life Sciences Reports First Quarter 2026 Financial Results and Provides Corporate Update

View all latest news

Achieve Life Sciences

Nicotine Dependence Company Achieve Life Sciences develops cytisinicline as a treatment for nicotine dependence and smoking cessation. Cytisinicline Cytisinicline is a plant-derived partial agonist of the nicotinic acetylcholine receptor and is intended as a shorter-course alternative to existing prescription therapies. Phase 3...

Recent company news

ACHVAchieve Life Sciences2026-08-03 12:30 EST

Achieve Life Sciences Appoints Ronald Dadino and Gloria Cosgrove to Lead CMC, Supply Chain, and Quality

ACHVAchieve Life Sciences2026-07-31 12:30 EST

Achieve Life Sciences Announced Granting of New Hire Inducement Awards

ACHVAchieve Life Sciences2026-06-29 12:30 EST

Achieve Life Sciences Joins Russell 2000® Index

ACHVAchieve Life Sciences2026-06-22 12:30 EST

Achieve Life Sciences Receives Complete Response Letter from FDA for Cytisinicline NDA

ACHVAchieve Life Sciences2026-06-02 12:30 EST

Achieve Life Sciences Appoints Jeffrey Farrow and Reid Waldman, MD to Board of Directors

Stock data

Close
6.55 USD
Market cap
516.38M USD
Exchange
NASDAQ
Sector
Life Science Tools
Location
United States